BioengineeringbioRxivPreprint
A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice
B. Pandey, Z. Wang, A. Jimenez…·K. Roy
This study develops a mucosal nanovaccine that enhances both systemic and lung-specific immunity against SARS-CoV-2 in mice through intranasal and intramuscular delivery.
DOI 10.1101/2023.05.05.539395